Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Jun 9;16(1):36.
doi: 10.1186/s12937-017-0259-0.

Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study

Paula Simplício da Silva  1 , Mauro Felippe Felix Mediano  2 , Gilberto Marcelo Sperandio da Silva  2 , Patricia Dias de Brito  3 , Claudia Santos de Aguiar Cardoso  3 , Cristiane Fonseca de Almeida  3 , Luiz Henrique Conde Sangenis  2 , Roberta Olmo Pinheiro  4 , Alejandro Marcel Hasslocher-Moreno  2 , Pedro Emmanuel Alvarenga Americano do Brasil  2 , Andrea Silvestre de Sousa  2
Affiliations
Randomized Controlled Trial

Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study

Paula Simplício da Silva et al. Nutr J. .

Abstract

Background: Several studies have been focusing on the effect of omega-3 polyunsaturated fatty acids on modulation of inflammatory markers in several cardiopathies. Although immunoregulatory dysfunction has been associated to the chronic cardiac involvement in Chagas disease, there is no study examining the effects of omega-3 supplementation in these patients. We investigated the effects of omega-3 PUFAs on markers of inflammation and lipid profile in chronic Chagas cardiomyopathy patients.

Methods: The present study was a single-center double-blind clinical trial including patients with chronic Chagas cardiomyopathy. Patients were randomly assigned to receive omega-3 PUFAs capsules (1.8g EPA and 1.2g DHA) or placebo (corn oil) during an 8-week period. Cytokines, fasting glucose, lipid, and anthropometric profiles were evaluated.

Results: Forty-two patients (23 women and 19 men) were included in the study and there were only two losses to follow-up during the 8-week period. Most of sociodemographic and clinical characteristics were similar between the groups at baseline, except for the cytokines IL-1β, IL-6, IL-8, IL-10, IL-17α, and IFNγ. The omega-3 PUFAs group demonstrated greater improvements in serum triglycerides (-21.1 vs. -4.1; p = 0.05) and IL-10 levels (-10.6 vs. -35.7; p = 0.01) in comparison to controls after 8 weeks of intervention. No further differences were observed between groups.

Conclusion: Omega-3 PUFAs supplementation may favorably affect lipid and inflammatory profile in chronic Chagas cardiomyopathy patients, demonstrated by a decrease in triglycerides and improvements on IL-10 concentration. Further studies examining the clinical effects of omega-3 fatty acids supplementation in chronic Chagas cardiomyopathy are necessary.

Trial registration: NCT01863576.

Keywords: Chagas cardiomyopathy; Chagas disease; Cytokines; Lipid profile; Omega-3.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Progress of participants through the trial
See this image and copyright information in PMC

References

    1. Rassi A, Jr, Rassi A, Marcondes de Rezende J. American Trypanosomiasis (Chagas Disease) Infect Dis Clin North Am. 2012;26:275–91. doi: 10.1016/j.idc.2012.03.002. - DOI - PubMed
    1. WHO | Chagas disease (American trypanosomiasis) [Internet]. WHO. [cited 2017 Feb 19]. Available from: http://www.who.int/mediacentre/factsheets/fs340/en/
    1. Coura JR, Viñas PA. Chagas disease: a new worldwide challenge. Nature. 2010;465:S6–7. doi: 10.1038/nature09221. - DOI - PubMed
    1. Marin Neto JA, Simões MV, Sarabanda AV. Chagas’ heart disease. Arq Bras Cardiol. 1999;72:247–80. doi: 10.1590/S0066-782X1999000300001. - DOI - PubMed
    1. Rocha MOC, Ribeiro ALP, Teixeira MM. Clinical management of chronic Chagas cardiomyopathy. Front Biosci J Virtual Libr. 2003;8:e44–54. doi: 10.2741/926. - DOI - PubMed

Publication types

MeSH terms

Associated data